Cargando…
Integrative learning in developing an immunologic lncRNA signature as a consensus risk-stratification tool for lung adenocarcinoma
BACKGROUND: In the tumor immune microenvironment, the contribution of innate and adaptive immune cells to tumor progression has been consistently demonstrated. However, reliable prognostic biomarkers for lung adenocarcinoma (LUAD) have not yet been identified. We thus developed and validated an immu...
Autores principales: | Chen, Zijian, Liu, Yangqi, Wan, Changhong, Huang, Weizhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183502/ https://www.ncbi.nlm.nih.gov/pubmed/37197549 http://dx.doi.org/10.21037/jtd-23-372 |
Ejemplares similares
-
Pyroptosis-Related LncRNA Signatures Correlate With Lung Adenocarcinoma Prognosis
por: Huang, Hua, et al.
Publicado: (2022) -
An immune-related lncRNA signature for the prognosis of pancreatic adenocarcinoma
por: Qi, Bing, et al.
Publicado: (2021) -
An Aggrephagy-Related LncRNA Signature for the Prognosis of Pancreatic Adenocarcinoma
por: Huang, Xueyuan, et al.
Publicado: (2023) -
An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma
por: Jiang, Xin, et al.
Publicado: (2023) -
cGAS–STING pathway in ischemia-reperfusion injury: a potential target to improve transplantation outcomes
por: Chen, Zijian, et al.
Publicado: (2023)